Learning Tracks

Biosimilars – Keys to Success in the Pharmacy Benefit

11:00 a.m. - 12:00 p.m.

The market entry of biosimilar insulin and multiple versions of biosimilar Humira have signaled a new era in biosimilar competition. As primarily pharmacy-benefit products, the opportunities and challenges for adoption can vary from those facing provider-administered biosimilars. This panel will review the state of the market and any lessons from the launches to date.


Nick Adolph
Principal – US Market Access Strategy, IQVIA Institute for Human Data Science

Alex Brill
CEO, Matrix Global Advisors

Sarah D’Orsie
Vice President, Government Affairs and Policy, Fresenius Kabi, Inc.


Melissa Andel, MPP
Principal, CommonHealth Solutions